1(2018) Instituto Nacional de Câncer José Alencar Gomes Da Silva(INCA) - Prevention and Surveillance Coordination. Estimate 2018: incidence of cancer in Brazil. Rio de Janeiro: INCA.

2Mour J, Lima R, Salvajoli J V, Souhami L, Faria S L (2013) Tumorsof head and neck. In: (Org.). Radiation therapy in oncology. São Paulo: EditoraAtheneu . 505-515.

3Lanzós i. et al. (2015) A critical assessment of oral care protocols for patients under radiation therapy in the regional University Hospital Network of Madrid (Spain). J Clin Exp Dent 7:. 613- 621.

4Ang K (2011) A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC). J ClinOncol 29: 5500.

5Forastiere A et al. (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349: 2091–2098.

6Hara W (2015) General principles of radiation therapy for head and neck cancer. UpToDate.

7Trotti A et al. (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66: 253–62.

8Langendijk J et al. (2008) Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J ClinOncol 26: 3770–3776.

9Justino P, Carvalho H, Ferauche D, Ros Rs (2003) Planejamento tridimensional para radioterapia de tumores de esôfago: comparaçã o de técnicas de tratamento e análise de probabilidade de complicações.RadiolBras 36 :157- 162.

10Santos M, Garcia P (2013) The financial impact of the incorporation of IMRT and RapidArcTM techniques on shielding calculation of a linear accelerator. RevistaBrasileira de FísicaMédica. 7 : 61-64.

11Wang X, Eisbruch A (2016) IMRT for head and neck cancer: reducing xerostomia and dysphagia. Journal of Radiation Research. 57 : i69–i75

12Kuhnt T,Stang A ,Wienke A, Vordermark D, Schweyen R et al.(2016) Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer. RadiatOncol. 11: 101.

13Freedman L (2015) A radiation oncologist's guide to contouring the larynx. PractRadiatoncol. 6: 129-30. Treatment of oral mucositis induced by radio and chemo-induced: comparison between conventional drug protocol and low intensity laser treatments. Dissertation.São Paulo: University of São Paulo; Institute of Energy and Nuclear Research, 2011.

14Rouers M et al. (2015) Maxillary and mandible contouring in patients with a head and neck area irradiation. PractRadiatOncol. 6:e61–72

15Freedman L, Sidani C (2016) A Radiation Oncologist’s Guide to Contouring the Parotid Gland. PractRadiatOncol.

16Brouwer C et al. (2015) CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiotherapy Oncol J European SocTher Radiology Oncol.117: 83–90.

17Marks L et al. ( 2010) Use of Normal Tissue Complication Probability Models in the Clinic. International Journal of Radiation Oncology*Biology*Physics. 76: S10–S19.

18(2009) National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Published: May 28, (v4.03:June 14, 2010) .

19Huang C J et al. (2015) RTOG, CTCAE and WHO criteria for acute radiation dermatites correlate with cutaneous blood flow measurements.Breast. 24 : 230

20Paula J, Sawada N O (2015) Qualidade de vida relacionada à saúde de pacientes com câncer em tratamento radioterápico. Rev Rene, 16 : 106-113,.

21GALBIATTI A et al. (2012) Head and neck cancer: genetic polymorphisms and folate metabolism. Braz J Otorhinolaryngol, 78 : 132- 139.S

22Poon C, Kerstin M Overview of the diagnosis and staging of head and neck cancer. UpToDate2015.

23AMERICAN CANCER SOCIETY. Cancer facts & figures 2018.Atlanta, 2018.

24CHUFAL K. et al. (2006) Analysis of prognostic variables among patients with locally advanced head and neck cancer treated with late chemo-intensification protocol: impact of nodal density and total tumor volume. Jpn J ClinOncol, 36: 537–46.

25Poulsen M et al. (2008) Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone. RadiotherOncol, 87: 253–259.

26Alencar A (2011) Tratamento da mucosite oral induzida por radio e quimioinduzida: comparação entre protocolo medicamentoso convencional e tratamentos com lasers em baixa intensidade. Dissertação. São Paulo: Universidade de São Paulo; Instituto de Pesquisas Energéticas e Nucleare.

27Matuschek C et al. (2016) Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients. RadiotherOncol 120: 28–35.

28Lionel D, Christophe L, Marc A, Jean-Luc C (2006) Oral mucositis induced by anticancer treatments: physiopathology and treatments. Ther Clin Risk Manag 2: 159-168.

29Rodriguez-Caballero A et al. (2012) Cancer treatment-induced oral mucositis: a critical review. Int J Oral MaxillofacSurg 41: 225–238.

30Hsu P-Y et al. (2016) Efficacy of Traditional Chinese Medicine in Xerostomia and Quality of Life during Radiotherapy for Head and Neck Cancer: A Prospective Pilot Study. Evidence-based Complementary and Alternative Medicine : eCAM, 2016: 8359251.

31Fávaro R,Ferreira T, Martins W (2006) Xerostomia: etiologia, diagnóstico e tratamento. Clin. Pesq. Odontol, Curitiba 2 : 303-317.